APA (7th ed.) Citation

Correa, R., Morton, G., Chung, H., Tseng, C., Cheung, P., Chu, W., . . . Loblaw, A. (2022). PO-1408 Two-fraction prostate SABR vs. two-fraction HDR brachytherapy: Does dose heterogeneity matter? Radiotherapy & Oncology, 170, S1193. https://doi.org/10.1016/S0167-8140(22)03372-2

Chicago Style (17th ed.) Citation

Correa, R., et al. "PO-1408 Two-fraction Prostate SABR Vs. Two-fraction HDR Brachytherapy: Does Dose Heterogeneity Matter?" Radiotherapy & Oncology 170 (2022): S1193. https://doi.org/10.1016/S0167-8140(22)03372-2.

MLA (9th ed.) Citation

Correa, R., et al. "PO-1408 Two-fraction Prostate SABR Vs. Two-fraction HDR Brachytherapy: Does Dose Heterogeneity Matter?" Radiotherapy & Oncology, vol. 170, 2022, p. S1193, https://doi.org/10.1016/S0167-8140(22)03372-2.